Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 737-742

  Santin, Alessandro D ^a,c,d   Hermonat, Paul L ^a   Hiserodt, John C ^b   Chiriva Internati, Maurizio ^a   Woodliff, Jeff ^a   Theus, John W ^a   Barclay, David ^a   Pecorelli, Sergio ^c   Parham, Groesbeck P ^a  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

Cervical cancer; ICAM 1; Irradiation; MHC

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MEGAVOLTAGE RADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; DOSE FRACTIONATION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; TUMOR CELLS, CULTURED; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 0030959701     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00372-6     Document Type: Article

References (26)

1. Anichini, A.; Mortarini, R.; Alberti, S.; Mantovani, A.; Parmiani, G. T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int. J. Cancer 53:994-1001; 1993.
2. Brinton, L. A. Epidemiology of cervical cancer: Overview. In: Munoz, N.; Bosh, F.; Shah, K. V.; Meheus, A., eds. The epidemiology of Human Papillomavirus and cervical cancer. Vol. 119. Lyon, France: IARC Science Publications; 1992:3-23.
3. Cameron, R. B.; Spiess, P. J.; Rosenberg S. A. Synergistic antitumor activity of tumor infiltrating lymphocytes, interleukin-2 and local tumor irradiation: Studies on the mechanism of action. J. Exp. Med. 171:249-263; 1990.
4. Chen, L.; Thomas, E. K.; Hu, S.-L.; Hellstrom, I.; Hellstrom, K. E. Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc. Natl. Acad. Sci. USA 88:110-114; 1991.
5. Coleman, N.; Stanley, M. A. Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. Int. J. Cancer 56:314-319; 1994.
6. Connor, M. E.; Stern, P. L. Loss of MHC Class-I expression in cervical carcinomas. Int. J. Cancer 46:1029-1034; 1990.
7. DiSaia, P. J.; Creasman, W. T. Epithelial ovarian cancer. In: P. J. DiSaia, P. J.; Creasman, W. T. eds., Clinical gynecologic oncology. St. Louis: Mosby-Year Book, Inc.; 1-36. 1993:
8. Dranoff, G.; Jaffee, E.; Lazenby, A.; Golumbek, P.; Levitsky H.; Brose, K.; Jacson, V.; Hamada, H.; Pardoll, D.; Mulligan, C. R. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539-3543; 1993.
9. Hall, E. J. Time, dose, and fractionation in radiotherapy. In: Radiobiology for the radiologist, 3rd ed. Philadelphia: J. B. Lippincott Company; 1988:239-259.
10. Hareyama, M.; Imai, K.; Kubo, K.; Takahashi, H.; Koshiba, H.; Hinoda, Y.; Shidou, M.; Oouchi, A.; Yachi, A.; Kazuo M. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer 67: 2269-2274; 1991.
11. b in B16 melanoma cells. Cancer Res. 53:1952-1955; 1993.
12. Honma, S.; Tsukada, S.; Honda, S.; Nakamura, M.; Takakuwa, K.; Maruhashi, T. Biological-clinical significance of selective loss of HLA-class I allelic product expression in squamous-cell carcinoma of the uterine cervix. Int. J. Cancer 57:650-655; 1994.
13. McFadden, G.; Kane, K. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv. Cancer Res. 63:117-209; 1994.
14. Melief, C.J.M.; Kast, W.M. Lessons from T cell responses to virus induced tumors for cancer eradication in general. Cancer Surv. 13:81-99; 1992.
15. Meneguzzi, G.; Cerni, C.; Kieny, M. P.; Lathe, R. Immunization against human papilloma virus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181:62-69; 1991.
16. Oboshi, S.; Shimosato, Y.; Itakura, K.; Umegaky, S. Radiation pathology for cancer: II. The immunological significance of the infiltration of lymphocytes surrounding the tumor tissue during irradiation. Igakunoayumi 61:725-730; 1967.
17. Ogawa, Y.; Maeda, T.; Seguchi, H. Evidence of existence of low dose radiation induced tumor immunity. Nippon Igaku Hoshasen Gakkai Zasshi 48:1572-1574; 1988.
18. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399-415; 1995.
19. Penn, I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 58:611-616; 1988.
20. Rellihan, M. A.; Dooley, D. P.; Burke, T. W.; Berkland, M. E.; Longfield, R. N. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol. Oncol 36:435-438; 1990.
21. Resnick, R. M.; Cornelissen, M. T. E.; Wright, D. K.; Eichinger, G. H.; Fox, H. S.; Schegget, J. Detection and typing of human papilloma virus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82:1477-1484; 1990.
22. Santin, A. D.; Ioli, G. R.; Hiserodt, J. C.; Rose G. S.; Graf M. R.; Tocco, L. M.; Lander, J. K.; Eck, L. M.; DiSaia, P. J.; Pecorelli, S.; Granger, G. A. Development and characterization of an IL-4 secreting human ovarian carcinoma cell line. Gynecol. Oncol. 58:230-239; 1995.
23. Taylor, J. L.; Grossberg, S.E. Recent progress in interferon research: Molecular mechanisms of regulation, action and virus circumvention. Virus Res. 15:1-26; 1990.
24. Vanky, F.; Wang, P.; Patattoyo, M.; Klein, E. Expression of the adhesion molecule ICAM-1 and the major histocompatibility complex antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother 31:19-27; 1990.
25. van Seventer, G.A.; Bonvini, E.; Yamada, H.; Conti, A.; Strigfellow, S.; June, C.; Shaw, S. Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular cell adhesion molecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+ levels. J. Immunol. 149:3872-3880; 1992.
26. Zamai, L.; Rana, R.; Mazzotti, G.; Centurione, L.; Di Pietro, R.; Vitale M. Lymphocyte binding to K562 cells: Effects of target cell irradiation and correlation with ICAM-1 and LFA-3 expression. Eur. J. Histochem. 38(Suppl 1):53-60; 1994.